Acceptor Regulation of Acceptor–Donor–Acceptor Type Conjugated Oligomer for Photothermal Combating of Resistant Bacteria
Source abstract
Abstract
Extensive efforts have been devoted to the development of photothermal agents (PTAs) to make photothermal therapy (PTT) flourish. Herein, we report three conjugated oligomer PTAs (BTP-2ThCl, BTP-2F-ThCl, and BTP-4F) with acceptor–donor–acceptor (A–D–A) structures to verify that connecting the stronger electron-absorbing acceptor groups is favored to amplify their optical properties. The optimal BTP-4F nanoparticles exhibited a photothermal conversion efficiency as high as 83% and antibacterial activity of over 99.9% against Escherichia coli with ampicillin resistance (Ampr E. coli). The design strategy of structure regulation at the molecular level opens an avenue for application of high-performance PTAs in PTT.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials · Perovskite Materials and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry, College of Chemistry and Materials Engineering, Beijing Technology and Business University, Beijing 100048, People’s Republic of China
Department of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, People’s Republic of China
Funding
Beijing Technology and Business University · National Natural Science Foundation of China
References (28)
Show source-provided references
1. 10.1039/D1CS00074H10.1039/D1CS00074H ↗
2. 10.1039/D0CS00664E10.1039/D0CS00664E ↗
3. 10.1002/adma.20200448110.1002/adma.202004481 ↗
4. 10.1002/adma.20190288510.1002/adma.201902885 ↗
5. 10.1038/s41467-020-15427-110.1038/s41467-020-15427-1 ↗
6. 10.1002/adfm.20140276210.1002/adfm.201402762 ↗
7. 10.1016/j.matt.2019.03.00710.1016/j.matt.2019.03.007 ↗
8. 10.7150/thno.1456610.7150/thno.14566 ↗
9. 10.1016/j.actbio.2018.07.03010.1016/j.actbio.2018.07.030 ↗
10. 10.1016/j.joule.2021.05.00210.1016/j.joule.2021.05.002 ↗
11. 10.1016/j.nantod.2021.10128910.1016/j.nantod.2021.101289 ↗
12. 10.1002/aenm.20190424710.1002/aenm.201904247 ↗
13. 10.1002/anie.20170988710.1002/anie.201709887 ↗
14. 10.1039/D1TC03128G10.1039/D1TC03128G ↗
15. 10.1002/adma.20200848110.1002/adma.202008481 ↗
16. 10.1002/adma.20200114610.1002/adma.202001146 ↗
17. 10.1021/acsnano.9b0538310.1021/acsnano.9b05383 ↗
18. 10.1021/acsami.0c2188910.1021/acsami.0c21889 ↗
19. 10.1002/adma.20190785510.1002/adma.201907855 ↗
20. 10.1002/smll.20200090910.1002/smll.202000909 ↗
21. 10.1039/C9MH00660E10.1039/C9MH00660E ↗
22. 10.1021/jacs.8b1388910.1021/jacs.8b13889 ↗
23. 10.1007/s11426-021-1055-010.1007/s11426-021-1055-0 ↗
24. 10.1021/acsami.1c1402010.1021/acsami.1c14020 ↗
25. 10.1016/j.joule.2020.03.02310.1016/j.joule.2020.03.023 ↗
26. 10.1016/j.joule.2019.01.00410.1016/j.joule.2019.01.004 ↗
27. 10.1002/aenm.20190004110.1002/aenm.201900041 ↗
28. 10.1002/anie.20210140610.1002/anie.202101406 ↗